Table 1.
Variables | Tumor circRNA0003906 expression
|
P-valuea | |
---|---|---|---|
Low | High | ||
Age | 0.419 | ||
<60 years | 19 | 15 | |
≥60 years | 42 | 46 | |
Gender | 0.308 | ||
Male | 47 | 42 | |
Female | 14 | 19 | |
Tumor diameter | 0.560 | ||
<5 cm | 40 | 43 | |
≥5 cm | 21 | 18 | |
Differentiation | 0.026 | ||
Well + moderate | 31 | 43 | |
Poor | 30 | 18 | |
T classification | 0.147 | ||
1–2 | 25 | 33 | |
3–4 | 36 | 28 | |
N classification | <0.001 | ||
0 | 21 | 46 | |
1–2 | 40 | 15 | |
TNM stage | 0.146 | ||
I–II | 29 | 37 | |
III–IV | 32 | 24 | |
CEA | 0.389 | ||
Negative | 45 | 49 | |
Positive | 16 | 12 | |
CA199 | 0.783 | ||
Negative | 54 | 53 | |
Positive | 7 | 8 |
Notes: CRC patients receiving radical operation were segregated into circRNA0003906 high/low expression groups (calculation of cut-off by ROC analysis).
Statistical analyses were performed with χ2 test or Fisher’s exact test.
Abbreviations: CA199, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; CRC, colorectal cancer; ROC, receiver operating characteristics.